Cargando…
Combination therapy for cancer with oncolytic virus and checkpoint inhibitor: A mathematical model
Oncolytic virus (OV) is a replication competent virus that selectively invades cancer cells; as these cells die under the viral burden, the released virus particles proceed to infect other cancer cells. Oncolytic viruses are designed to also be able to stimulate the anticancer immune response. Thus,...
Autores principales: | Friedman, Avner, Lai, Xiulan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805294/ https://www.ncbi.nlm.nih.gov/pubmed/29420595 http://dx.doi.org/10.1371/journal.pone.0192449 |
Ejemplares similares
-
Combination therapy of cancer with cancer vaccine and immune checkpoint inhibitors: A mathematical model
por: Lai, Xiulan, et al.
Publicado: (2017) -
Combination therapy for melanoma with BRAF/MEK inhibitor and immune checkpoint inhibitor: a mathematical model
por: Lai, Xiulan, et al.
Publicado: (2017) -
Combination therapy for mCRPC with immune checkpoint inhibitors, ADT and vaccine: A mathematical model
por: Siewe, Nourridine, et al.
Publicado: (2022) -
How to schedule VEGF and PD-1 inhibitors in combination cancer therapy?
por: Lai, Xiulan, et al.
Publicado: (2019) -
Exosomal miRs in Lung Cancer: A Mathematical Model
por: Lai, Xiulan, et al.
Publicado: (2016)